Contributions and Events
DENVER – The use of hybrid capture-based (HC-based) next-generation sequencing (NGS) to identify targetable oncogenic drivers in patients with lung adenocarcinoma results in the detection of genomic alterations (GAs) not identified in routine screening, and impacts treatment decisions and clinical outcomes.
Personalized Medicine Talking Points
Lung Cancer Awareness Month
TOPIC: Personalized Medicine –Laymen’s Summary and Main Message
Personalized Medicine - Laymen's Summary and Main Message
March 2017 Newsletter
The management of patients with thoracic cancers presents both unique opportunities as well as challenges.